Literature DB >> 17368034

Conformational analysis of endomorphin-2 analogs with phenylalanine mimics by NMR and molecular modeling.

Xuan Shao1, Yanfeng Gao, Chuanjun Zhu, Xuehui Liu, Jinlong Yao, Yuxin Cui, Rui Wang.   

Abstract

We investigated a series of conformations of endomorphin-2 (EM-2) analogs substituted by phenylglycine (Phg) and homophenylalanine (Hfe) in the position 3 or 4 by two-dimensional (1)H NMR spectroscopy and molecular modeling. Evaluating the aromatic interactions and the dihedral angles in these phenylalanine mimics, we have observed that the conformations in trans isomer have varied from extended to folded as bioactivity decreases. It is suggested that the flexibility of aromatic side chain affects the backbone of EM-2 to adopt folded structures, which may block the ligands in binding to micro-opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368034     DOI: 10.1016/j.bmc.2007.02.050

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Federica Feliciani; Gino Lucente; Giancarlo Fabrizi; Gustavo Portalone; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

2.  Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Engin Bojnik; Anna Borsodi; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  Mol Divers       Date:  2012-11-04       Impact factor: 2.943

3.  Four-component pharmacophore model for endomorphins toward μ opioid receptor subtypes.

Authors:  Yng-Ching Wu; Tim Jaglinski; Jin-Yuan Hsieh; Jia-Jyun Chiu; Tzen-Yuh Chiang; Chi-Chuan Hwang
Journal:  J Mol Model       Date:  2011-05-27       Impact factor: 1.810

Review 4.  Engineering endomorphin drugs: state of the art.

Authors:  Lawrence H Lazarus; Yoshio Okada
Journal:  Expert Opin Ther Pat       Date:  2012-01-04       Impact factor: 6.674

5.  Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics.

Authors:  Giordano Lesma; Severo Salvadori; Francesco Airaghi; Thomas F Murray; Teresa Recca; Alessandro Sacchetti; Gianfranco Balboni; Alessandra Silvani
Journal:  ACS Med Chem Lett       Date:  2013-07-11       Impact factor: 4.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.